Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list